Where is Acadia headquartered?

Acadia is located in San Diego, CA.

Who invested in Acadia?

Acadia has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Acadia?

Acadia closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

acadia-pharm.com

Acadia

ACADIA Pharmaceuticals focused on the development and commercialization of innovative therapies for central nervous system disorders.

Business Model:

Revenue: $511.5M

Employees: 501-1,000

Geographic Data

Address: 12830 El Camino Real

City: San Diego

State: CA

Zip: 92130

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$288M

Raised Total:

$557M

Social

Facebook

Twitter

Crunchbase

Metrics

1,407,633Website Global Rank

19,367Website Monthly Traffic

Twitter Followers

Description

ACADIA Pharmaceuticals focused on the development and commercialization of innovative therapies for central nervous system disorders.

Contact Phone:
+18585582871

Contact Email:

IPO Details

Acadia went public on 5/27/2004 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
5/27/2004

IPO Valuation:
$112M

Ticker Symbol:
ACAD

IPO Price:
$7/share

Amount Raised:
$35M

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
8/1997	Series B		$0	DKA Capital LD Pensions BankInvest DKA Capital LD Pensions BankInvest
2/1997	Debt Financing	1	$7.5M	Vaekstfonden Vaekstfonden
5/2011	Grant	1	$2.4M	National Institute of Neurological Disorders and Stroke National Institute of Neurological Disorders and Stroke National Institute of Neurological Disorders and Stroke National Institute of Neurological Disorders and Stroke
12/2012	Post-IPO Equity		$86.4M
11/2018	Post-IPO Equity		$316.2M
1/2011	Post-IPO Equity		$21.1M
12/2010	Post-IPO Equity		$15M	Venrock New Enterprise Associates
1/2013	Post-IPO Equity		$86.4M
9/2019	Post-IPO Equity		$287.5M
11/2018	Post-IPO Equity		$316.2M
7/2000	Grant	1	-	National Institute of Mental Health National Institute of Mental Health
2/2005	Post-IPO Equity	1	$10M	Oxford Bioscience Partners Oxford Bioscience Partners
1/2011	Post-IPO Equity	2	$15M	New Enterprise Associates Venrock New Enterprise Associates Venrock
2/1997	Series A	3	$6M	LD Pensions DKA Capital BankInvest LD Pensions DKA Capital BankInvest
2/2006	Post-IPO Equity	2	$20M	Nomura International Oxford Bioscience Partners Nomura International Oxford Bioscience Partners
8/1998	Series D		$0	DKA Capital LD Pensions DKA Capital LD Pensions
3/2003	Series F	7	$25M	ABN AMRO Fund OrbiMed LD Pensions Federated Investors Oxford Bioscience Partners Hambrecht &a; Quist Capital Management Forbion Capital Partners ABN AMRO Fund OrbiMed LD Pensions Federated Investors Oxford Bioscience Partners
6/2000	Debt Financing		$0	H&a;Q Healthcare Investors DKA Capital OrbiMed Pacific Rim Ventures The Kaufmann Fund H&a;Q Healthcare Investors DKA Capital OrbiMed Pacific Rim Ventures The Kaufmann Fund
7/2000	Grant	1	-	National Institute of Mental Health National Institute of Mental Health
6/2000	Debt Financing	5	$22M	H&a;Q Healthcare Investors H&a;Q Healthcare Investors

Acquisitions

Announced Date	Name	Price
8/2020	CerSci Therapeutics

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details